Answers are grounded in this paper and cite their sources.
reductions indicated changes consistent with demyelination in the corpus callosum and deep cerebellar nuclei by Day 24, expanding to cortex and hippocampus by Day 35. Only partial recovery was observed by Day 77, consistent with histological evidence. TBM revealed dynamic volumetric alterations, including hippocampal and cerebellar expansion alongside cortical and subcortical shrinkage, persisting beyond CPZ cessation. DTI demonstrated early (Days 24-35) decreases in FA and MD, followed by complex trajectories consistent with microstructural disruption and partial repair. MRS detected early increases in GABA, glutamine, taurine, and glutathione, with corresponding decreases in NAA, while inositol showed a biphasic decrease-increase profile, likely reflecting acute astrocytic dysfunction followed by gliosis - neuroinflammatory processes that were corroborated by immunohistochemistry. Together, these results demonstrate that multimodal MRI/MRS sensitively captures widespread, dynamic, and only partially reversible pathology in CPZ-treated mice. Longitudinal imaging provides a non-invasive, translational approach to characterising demyelination, gliosis, and remyelination, offering a powerful complement to histology for preclinical studies and longitudinal therapeutic screening.
No takes yet. Share an insight, caveat, or question.
Walters et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: